Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Hong-qing ZHUANG"'
Publikováno v:
Cancer Biology & Medicine, Vol 7, Iss 4, Pp 246-252 (2010)
OBJECTIVE To identify risk factors for relapse and death in patients with T1 to T2 breast cancer with 0-3 positive axillary lymph nodes.METHODS The case files of 540 breast cancer patients with T1-T2 tumors with 0-3 positive nodes were reviewed retro
Externí odkaz:
https://doaj.org/article/c6d51be297f347aa888909e5eb0f08ec
Autor:
Ting-Shi Su, Shi-Xiong Liang, Li-Qing Li, Qiu-Hua Liu, Xue-Zhang Duan, Jing Sun, Hai Zeng, Hai-Sheng Zhu, Jian-Xu Li, Xiao-Fei Zhu, Hong-Qing Zhuang, Ping Liang, Yong Huang
Publikováno v:
Journal of Clinical and Translational Hepatology. :000-000
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8f381809fae1e6b4ef5fb5d2d08e814
https://doi.org/10.14218/jcth.2022.00002
https://doi.org/10.14218/jcth.2022.00002
Publikováno v:
Cancer Biomarkers. 19:45-50
BACKGROUND Radiosensitivity by blocking the epidermal growth factor receptor and cyclooxygenase-2 pathways with erlotinib and celecoxib in A549 human lung cancer cell was investigated. METHODS MTT assays were used to detect the antitumor effects of e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b2a4ba892d12cc54583214108eb564
https://doi.org/10.3233/cbm-160323
https://doi.org/10.3233/cbm-160323
Autor:
Xu Dong Jiang, Zhong Jun Liu, Yi Ning Gong, Xiao Guang Liu, Feng Wei, Liang Jiang, Hong Qing Zhuang, Na Meng, Jin Xin Hu
Publikováno v:
World neurosurgery. 141
Background We sought to compare local tumor control after conventionally fractionated image-guided intensity-modulated radiotherapy (IMRT) versus adjuvant CyberKnife stereotactic body radiotherapy (SBRT) in patients who underwent separation surgery f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::564625731b307614ca328f72ff609234
https://pubmed.ncbi.nlm.nih.gov/32360927
https://pubmed.ncbi.nlm.nih.gov/32360927
Autor:
Yong Chun Song, Ping Wang, Dong Qian, Zhi Yong Yuan, Hong Qing Zhuang, Xian Liang Zeng, Mao Bin Meng, Zhiqiang Wu, Lu Jun Zhao, Feng Tong Li, Huan Huan Wang
Publikováno v:
OncoTargets and therapy
Xian-Liang Zeng,* Huan-Huan Wang,* Mao-Bin Meng, Zhi-Qiang Wu, Yong-Chun Song, Hong-Qing Zhuang, Dong Qian, Feng-Tong Li, Lu-Jun Zhao, Zhi-Yong Yuan, Ping Wang Department of Radiation Oncology, Tianjin’s Clinical Research Center for Cancer and Key
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33b4ff28ac223d876aa870d186859140
https://doi.org/10.2147/ott.s102784
https://doi.org/10.2147/ott.s102784
Autor:
Hong-Qing Zhuang1 hongqingzhuang@163.com, Qi-Fu Bo2, Zhi-Yong Yuan1, Jun Wang1, Lu-Jun Zhao1, Ping Wang1
Publikováno v:
OncoTargets & Therapy. 2013, Vol. 6, p603-608. 6p.
Autor:
Hong-qing Zhuang1 hongqingzh@163.com, Zhi-yong Yuan1, Jun Wang1, Ping Wang1, Lu-jun Zhao1, Bai-lin Zhang1
Publikováno v:
OncoTargets & Therapy. 2012 Part 2, Vol. 5, p263-270. 8p.
Autor:
Hong-Qing Zhuang1 hongqingzh@163.com, Jun-Jie Wang doctorwangjunjie@yahoo.com.cn, An-Yan Liao1 liaoanyan323@126.com, Ji-Dong Wang1 jidongwzs@163.com, Yong Zhao2 zhaoy@ioz.ac.cn
Publikováno v:
Journal of Experimental & Clinical Cancer Research (17569966). 2009, Vol. 28, p1-9. 9p. 1 Diagram, 3 Charts, 4 Graphs.
Publikováno v:
Recent Patents on Anti-Cancer Drug Discovery. 9:129-134
Bevacizumab, one of the best-known patents of VEGF inhibitor, has demonstrated significant radiosensitive effects on various preclinical tumor models and clinical trials recently. The radiosensitive effects of this novel patent have achieved satisfac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1c495210d96364eac878b5175edf232
https://doi.org/10.2174/15748928113089990044
https://doi.org/10.2174/15748928113089990044
Autor:
Yong Chun Song, Jun Wang, Hong Qing Zhuang, Zhong Jie Chen, Li Jun Tian, Lu Jun Zhao, Ping Wang, Qing Song Pang, Mao Bin Meng, Chunlei Liu, Z. Yuan, Chao Jiang
Publikováno v:
Thoracic Cancer. 4:174-185
Background Late course accelerated hyperfractionation radiotherapy (LCAHR) is used as a standard treatment option for locally advanced esophageal squamous cell carcinoma (LAESCC) in China, but concerns remain regarding its efficacy and safety. The pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::89d687f6a98ae594164f0753d0dcda8f
https://doi.org/10.1111/j.1759-7714.2012.00166.x
https://doi.org/10.1111/j.1759-7714.2012.00166.x